Logo image
USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?
Journal article   Peer reviewed

USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?

Kristen M Kreisel, O. Colin Stine, J. Kristie Johnson, Eli N Perencevich, Michelle D Shardell, Alan J Lesse, Fred M Gordin, Michael W Climo and Mary-Claire Roghmann
Diagnostic Microbiology & Infectious Disease, Vol.70(3), pp.285-290
07/2011
DOI: 10.1016/j.diagmicrobio.2011.03.010
PMID: 21558047
url
https://www.ncbi.nlm.nih.gov/pmc/articles/3118841View
Open Access

Abstract

USA300 methicillin-resistant Staphylococcus aureus (MRSA) is increasing as a cause of severe community-associated bacteremic infections. We assessed severe sepsis in response to infection in patients with USA300 MRSA compared to non-USA300 MRSA bacteremia. A cohort study was conducted from 1997 to 2008 comparing sepsis in response to infection in 271 patients with MRSA bacteremia from 4 VA hospitals. Sixty-seven (25%) patients with MRSA bacteremia were USA300 MRSA; 204 (75%) were non-USA300 MRSA. The proportion of MRSA bacteremia caused by USA300 MRSA increased over time (χ2P < 0.0001). Adjusting for age and nosocomial infection, patients with USA300 MRSA bacteremia were more likely to have severe sepsis or septic shock in response to infection than patients with non-USA300 MRSA bacteremia (adjusted relative risk = 1.82; 95% confidence interval, 1.16–2.87; P = 0.01). This suggests that patients with USA300 MRSA are more likely to develop severe sepsis in response to their infection, which could be due to host or bacterial differences.
Community-acquired infections Electrophoresis Pulsed-field Methicillin resistance Bacterial typing techniques Staphylococcus aureus Bacteremia Gel

Details

Metrics

Logo image